These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19274005)

  • 21. Estimation of Iranian stroke patients eligible for intravenous thrombolysis with tPA.
    Ghandehari K; Zahed AP; Taheri M; Abbasi M; Gorjestani S; Ahmadi AM; Nahayati MA
    Int J Stroke; 2009 Aug; 4(4):236. PubMed ID: 19689746
    [No Abstract]   [Full Text] [Related]  

  • 22. [Thrombolytic therapies in the emergency medical services].
    Aaltonen J; Kuisma M
    Duodecim; 2000; 116(10):1110-8. PubMed ID: 11989022
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thrombolytic therapy for acute ischemic stroke].
    Mori E
    Nihon Rinsho; 2006 Nov; 64 Suppl 8():33-7. PubMed ID: 17469531
    [No Abstract]   [Full Text] [Related]  

  • 24. PHANTOM-S: the prehospital acute neurological therapy and optimization of medical care in stroke patients - study.
    Ebinger M; Rozanski M; Waldschmidt C; Weber J; Wendt M; Winter B; Kellner P; Baumann AM; Malzahn U; Heuschmann PU; Fiebach JB; Endres M; Audebert HJ;
    Int J Stroke; 2012 Jun; 7(4):348-53. PubMed ID: 22300008
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Thrombolytic therapy with tPA for the treatment of acute stroke. The Standard Treatment with Alteplase to Reverse Stroke study].
    Di Pasquale G
    Ital Heart J Suppl; 2000 Jul; 1(7):947-8. PubMed ID: 10935744
    [No Abstract]   [Full Text] [Related]  

  • 26. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombolysis, community hospitals, and primary stroke center.
    Jeng JS
    Acta Neurol Taiwan; 2009 Mar; 18(1):1-2. PubMed ID: 19537567
    [No Abstract]   [Full Text] [Related]  

  • 28. Thrombolytic therapy for acute ischemic stroke: risks vs benefits.
    Lindbloom EJ
    J Fam Pract; 2003 Oct; 52(10):757, 761. PubMed ID: 14529595
    [No Abstract]   [Full Text] [Related]  

  • 29. Tissue plasminogen activator approved for stroke.
    Barber A; Gommans J
    N Z Med J; 2005 May; 118(1214):U1432. PubMed ID: 15886728
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A review of barriers to thrombolytic therapy: implications for nursing care in the emergency department.
    Johnson M; Bakas T
    J Neurosci Nurs; 2010 Apr; 42(2):88-94. PubMed ID: 20422794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Thrombolytic therapy in stroke approved with reservation. Underlying evidence, practical guidelines and safety follow up].
    Wahlgren NG
    Lakartidningen; 2004 Feb; 101(8):674-7. PubMed ID: 15024940
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute ischemic stroke: Not a moment to lose.
    Miller J; Mink J
    Nursing; 2009 May; 39(5):37-42; quiz 42-3. PubMed ID: 19395934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can emergency medicine physicians accurately identify i.v. t-PA eligible acute stroke patients?
    Smith WS
    Neurocrit Care; 2007; 7(2):101-2. PubMed ID: 17710377
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombolysis in stroke: still not ready for community hospital use by emergency physicians.
    McNamara RM
    Ann Emerg Med; 2009 Sep; 54(3):339-41. PubMed ID: 19695417
    [No Abstract]   [Full Text] [Related]  

  • 36. Early phase combined therapeutic management of acute ischaemic stroke.
    Bassi P; Lattuada P; Tonietti S
    Neurol Sci; 2005 May; 26 Suppl 1():S29-30. PubMed ID: 15883687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the number of stroke patients eligible for thrombolytic treatment if delay could be avoided.
    Boode B; Welzen V; Franke C; van Oostenbrugge R
    Cerebrovasc Dis; 2007; 23(4):294-8. PubMed ID: 17199087
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous thrombolysis for ischaemic stroke: short delays and high community-based treatment rates after organisational changes in a previously inexperienced centre.
    Tveiten A; Mygland A; Ljøstad U; Thomassen L
    Emerg Med J; 2009 May; 26(5):324-6. PubMed ID: 19386862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal impairment reduces the efficacy of thrombolytic therapy in acute ischemic stroke.
    Power A; Epstein D; Cohen D; Bathula R; Devine J; Kar A; Taube D; Duncan N; Ames D
    Cerebrovasc Dis; 2013; 35(1):45-52. PubMed ID: 23428996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of lack of improvement after thrombolytic stroke therapy.
    Pastewski A; Kupfer Y; Tessler S
    JAMA; 2005 Jan; 293(4):421; author reply 421. PubMed ID: 15671423
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.